NCT05765110View on ClinicalTrials.gov

SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

March 31, 2026

Conditions
Parkinson Disease
Interventions
OTHER

Dopaminergic OFF drug state

Experiment will be performed without dopaminergic medication

OTHER

DBS OFF state

Turning off the stimulation during experiment

OTHER

Dopaminergic ON drug state

Experiment will be performed with dopaminergic medication

OTHER

DBS ON state

Experiment will be performed with stimulation (ON condition)

Trial Locations (2)

3010

RECRUITING

University Hospital Inselspital, Berne, Bern

166 27

ACTIVE_NOT_RECRUITING

Czech Technical University Prague, Prague

All Listed Sponsors
collaborator

Czech Technical University in Prague

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER